{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:03:29Z","timestamp":1789427009355,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82171245"],"award-info":[{"award-number":["No. 82171245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["NO.ZR2023MH038"],"award-info":[{"award-number":["NO.ZR2023MH038"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00415-025-13086-0","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:52:05Z","timestamp":1746193925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of LRRK2 and GBA variants on orthostatic hypotension in patients with Parkinson\u2019s disease"],"prefix":"10.1007","volume":"272","author":[{"given":"Wen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinlian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinde","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7200-7197","authenticated-orcid":false,"given":"Yiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"13086_CR1","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, De Marco EV, D\u00fcrr A, Eblan MJ, Fahn S, Farrer MJ, Fung HC, Gan-Or Z, Gasser T, Gershoni-Baruch R, Giladi N, Griffith A, Gurevich T, Januario C, Kropp P, Lang AE, Lee-Chen GJ, Lesage S, Marder K, Mata IF, Mirelman A, Mitsui J, Mizuta I, Nicoletti G, Oliveira C, Ottman R, Orr-Urtreger A, Pereira LV, Quattrone A, Rogaeva E, Rolfs A, Rosenbaum H, Rozenberg R, Samii A, Samaddar T, Schulte C, Sharma M, Singleton A, Spitz M, Tan EK, Tayebi N, Toda T, Troiano AR, Tsuji S, Wittstock M, Wolfsberg TG, Wu YR, Zabetian CP, Zhao Y, Ziegler SG (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361:1651\u20131661. https:\/\/doi.org\/10.1056\/NEJMoa0901281","journal-title":"N Engl J Med"},{"key":"13086_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1042\/bst20180462","volume":"47","author":"JH Kluss","year":"2019","unstructured":"Kluss JH, Mamais A, Cookson MR (2019) LRRK2 links genetic and sporadic Parkinson\u2019s disease. Biochem Soc Trans 47:651\u2013661. https:\/\/doi.org\/10.1042\/bst20180462","journal-title":"Biochem Soc Trans"},{"key":"13086_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","volume":"16","author":"E Tolosa","year":"2020","unstructured":"Tolosa E, Vila M, Klein C, Rascol O (2020) LRRK2 in Parkinson disease: challenges of clinical trials. Nat Rev Neurol 16:97\u2013107. https:\/\/doi.org\/10.1038\/s41582-019-0301-2","journal-title":"Nat Rev Neurol"},{"key":"13086_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ceb.2020.01.001","volume":"63","author":"M Taylor","year":"2020","unstructured":"Taylor M, Alessi DR (2020) Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson\u2019s\u00a0disease. Curr Opin Cell Biol 63:102\u2013113. https:\/\/doi.org\/10.1016\/j.ceb.2020.01.001","journal-title":"Curr Opin Cell Biol"},{"key":"13086_CR5","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/mds.27490","volume":"33","author":"A Thaler","year":"2018","unstructured":"Thaler A, Kozlovski T, Gurevich T, Bar-Shira A, Gana-Weisz M, Orr-Urtreger A, Giladi N, Mirelman A (2018) Survival rates among Parkinson\u2019s disease patients who carry mutations in the LRRK2 and GBA genes. Mov Disord 33:1656\u20131660. https:\/\/doi.org\/10.1002\/mds.27490","journal-title":"Mov Disord"},{"key":"13086_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/ana.26636","volume":"94","author":"A Lanore","year":"2023","unstructured":"Lanore A, Casse F, Tesson C, Courtin T, Menon PJ, Sambin S, Mangone G, Mariani LL, Lesage S, Brice A, Elbaz A, Corvol JC (2023) Differences in survival across monogenic forms of Parkinson\u2019s disease. Ann Neurol 94:123\u2013132. https:\/\/doi.org\/10.1002\/ana.26636","journal-title":"Ann Neurol"},{"key":"13086_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.nrleng.2020.06.014","volume":"38","author":"G Fern\u00e1ndez-Pajar\u00edn","year":"2023","unstructured":"Fern\u00e1ndez-Pajar\u00edn G, Sesar \u00c1, Jim\u00e9nez-Mart\u00edn I, Ares B, Castro A (2023) Progression and treatment of a series of patients with advanced LRRK2-associated Parkinson\u2019s disease. Neurologia (Engl Ed) 38:350\u2013356. https:\/\/doi.org\/10.1016\/j.nrleng.2020.06.014","journal-title":"Neurologia (Engl Ed)"},{"key":"13086_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3389\/fneur.2019.00531","volume":"10","author":"T Kozlovski","year":"2019","unstructured":"Kozlovski T, Mitelpunkt A, Thaler A, Gurevich T, Orr-Urtreger A, Gana-Weisz M, Shachar N, Galili T, Marcus-Kalish M, Bressman S, Marder K, Giladi N, Benjamini Y, Mirelman A (2019) Hierarchical data-driven analysis of clinical symptoms among patients with Parkinson\u2019s disease. Front Neurol 10:531. https:\/\/doi.org\/10.3389\/fneur.2019.00531","journal-title":"Front Neurol"},{"key":"13086_CR9","doi-asserted-by":"publisher","first-page":"e814","DOI":"10.1212\/wnl.0000000000200737","volume":"99","author":"R Saunders-Pullman","year":"2022","unstructured":"Saunders-Pullman R, Ortega RA, Wang C, Raymond D, Elango S, Leaver K, Urval N, Katsnelson V, Gerber R, Swan M, Shanker V, Alcalay RN, Mirelman A, Brumm MC, Mejia-Santana H, Coffey CS, Marek K, Ozelius LJ, Giladi N, Marder KS, Bressman SB (2022) Association of olfactory performance with motor decline and age at onset in people with Parkinson disease and the LRRK2 G2019S variant. Neurology 99:e814\u2013e823. https:\/\/doi.org\/10.1212\/wnl.0000000000200737","journal-title":"Neurology"},{"key":"13086_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030736","author":"DEC Boer","year":"2020","unstructured":"Boer DEC, van Smeden J, Bouwstra JA, Aerts J (2020) Glucocerebrosidase: functions in and Beyond the Lysosome. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9030736","journal-title":"J Clin Med"},{"key":"13086_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040364","author":"GM Riboldi","year":"2019","unstructured":"Riboldi GM, Di Fonzo AB (2019) GBA, gaucher disease, and Parkinson\u2019s disease: from genetic to clinic to new therapeutic approaches. Cells. https:\/\/doi.org\/10.3390\/cells8040364","journal-title":"Cells"},{"key":"13086_CR12","doi-asserted-by":"publisher","first-page":"3136415","DOI":"10.1155\/2018\/3136415","volume":"2018","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Shu L, Zhou X, Pan H, Xu Q, Guo J, Tang B, Sun Q (2018) A meta-analysis of GBA-related clinical symptoms in Parkinson\u2019s disease. Parkinsons Dis 2018:3136415. https:\/\/doi.org\/10.1155\/2018\/3136415","journal-title":"Parkinsons Dis"},{"key":"13086_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/hmg\/ddq454","volume":"20","author":"S Lesage","year":"2011","unstructured":"Lesage S, Anheim M, Condroyer C, Pollak P, Durif F, Dupuits C, Viallet F, Lohmann E, Corvol JC, Honor\u00e9 A, Rivaud S, Vidailhet M, D\u00fcrr A, Brice A (2011) Large-scale screening of the Gaucher\u2019s disease-related glucocerebrosidase gene in Europeans with Parkinson\u2019s disease. Hum Mol Genet 20:202\u2013210. https:\/\/doi.org\/10.1093\/hmg\/ddq454","journal-title":"Hum Mol Genet"},{"key":"13086_CR14","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/mds.28195","volume":"35","author":"S Petrucci","year":"2020","unstructured":"Petrucci S, Ginevrino M, Trezzi I, Monfrini E, Ricciardi L, Albanese A, Avenali M, Barone P, Bentivoglio AR, Bonifati V, Bove F, Bonanni L, Brusa L, Cereda C, Cossu G, Criscuolo C, Dati G, De Rosa A, Eleopra R, Fabbrini G, Fadda L, Garbellini M, Minafra B, Onofrj M, Pacchetti C, Palmieri I, Pellecchia MT, Petracca M, Picillo M, Pisani A, Vallelunga A, Zangaglia R, Di Fonzo A, Morgante F, Valente EM (2020) GBA-related Parkinson\u2019s Disease: dissection of genotype-phenotype correlates in a large Italian cohort. Mov Disord 35:2106\u20132111. https:\/\/doi.org\/10.1002\/mds.28195","journal-title":"Mov Disord"},{"key":"13086_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/mds.26071","volume":"30","author":"K Brockmann","year":"2015","unstructured":"Brockmann K, Srulijes K, Pflederer S, Hauser AK, Schulte C, Maetzler W, Gasser T, Berg D (2015) GBA-associated Parkinson\u2019s disease: reduced survival and more rapid progression in a prospective longitudinal study. Mov Disord 30:407\u2013411. https:\/\/doi.org\/10.1002\/mds.26071","journal-title":"Mov Disord"},{"key":"13086_CR16","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1007\/s00415-023-11612-6","volume":"270","author":"N Yang","year":"2023","unstructured":"Yang N, Sang S, Peng T, Hu W, Wang J, Bai R, Lu H (2023) Impact of GBA variants on longitudinal freezing of gait progression in early Parkinson\u2019s disease. J Neurol 270:2756\u20132764. https:\/\/doi.org\/10.1007\/s00415-023-11612-6","journal-title":"J Neurol"},{"key":"13086_CR17","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/brain\/awp044","volume":"132","author":"J Neumann","year":"2009","unstructured":"Neumann J, Bras J, Deas E, O\u2019Sullivan SS, Parkkinen L, Lachmann RH, Li A, Holton J, Guerreiro R, Paudel R, Segarane B, Singleton A, Lees A, Hardy J, Houlden H, Revesz T, Wood NW (2009) Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease. Brain 132:1783\u20131794. https:\/\/doi.org\/10.1093\/brain\/awp044","journal-title":"Brain"},{"key":"13086_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1212\/wnl.0000000000003452","volume":"88","author":"J Centi","year":"2017","unstructured":"Centi J, Freeman R, Gibbons CH, Neargarder S, Canova AO, Cronin-Golomb A (2017) Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology 88:17\u201324. https:\/\/doi.org\/10.1212\/wnl.0000000000003452","journal-title":"Neurology"},{"key":"13086_CR19","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.3233\/jpd-202036","volume":"10","author":"A Fanciulli","year":"2020","unstructured":"Fanciulli A, Leys F, Falup-Pecurariu C, Thijs R, Wenning GK (2020) Management of orthostatic hypotension in Parkinson\u2019s disease. J Parkinsons Dis 10:S57-s64. https:\/\/doi.org\/10.3233\/jpd-202036","journal-title":"J Parkinsons Dis"},{"key":"13086_CR20","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.14336\/ad.2021.0214","volume":"12","author":"S Zhu","year":"2021","unstructured":"Zhu S, Li H, Xu X, Luo Y, Deng B, Guo X, Guo Y, Yang W, Wei X, Wang Q (2021) The pathogenesis and treatment of cardiovascular autonomic dysfunction in Parkinson\u2019s disease: what we know and where to go. Aging Dis 12:1675\u20131692. https:\/\/doi.org\/10.14336\/ad.2021.0214","journal-title":"Aging Dis"},{"key":"13086_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2011.06.047","volume":"310","author":"Y Sharabi","year":"2011","unstructured":"Sharabi Y, Goldstein DS (2011) Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease. J Neurol Sci 310:123\u2013128. https:\/\/doi.org\/10.1016\/j.jns.2011.06.047","journal-title":"J Neurol Sci"},{"issue":"163","key":"13086_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1056\/NEJMra1509723","volume":"382","author":"H Kaufmann","year":"2020","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA (2020) Baroreflex Dysfunction. N Engl J Med 382(163):178. https:\/\/doi.org\/10.1056\/NEJMra1509723","journal-title":"N Engl J Med"},{"key":"13086_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/ageing\/afp192","volume":"39","author":"S Kamaruzzaman","year":"2010","unstructured":"Kamaruzzaman S, Watt H, Carson C, Ebrahim S (2010) The association between orthostatic hypotension and medication use in the British Women\u2019s Heart and Health Study. Age Ageing 39:51\u201356. https:\/\/doi.org\/10.1093\/ageing\/afp192","journal-title":"Age Ageing"},{"key":"13086_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/hjh.0000000000000781","volume":"34","author":"Y Press","year":"2016","unstructured":"Press Y, Punchik B, Freud T (2016) Orthostatic hypotension and drug therapy in patients at an outpatient comprehensive geriatric assessment unit. J Hypertens 34:351\u2013358. https:\/\/doi.org\/10.1097\/hjh.0000000000000781","journal-title":"J Hypertens"},{"key":"13086_CR25","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1253\/circj.cj-14-0064","volume":"78","author":"H Tomiyama","year":"2014","unstructured":"Tomiyama H, Matsumoto C, Kimura K, Odaira M, Shiina K, Yamashina A (2014) Pathophysiological contribution of vascular function to baroreflex regulation in hypertension. Circ J 78:1414\u20131419. https:\/\/doi.org\/10.1253\/circj.cj-14-0064","journal-title":"Circ J"},{"key":"13086_CR26","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1097\/HJH.0b013e3283015e5a","volume":"26","author":"O Ormezzano","year":"2008","unstructured":"Ormezzano O, Cracowski JL, Quesada JL, Pierre H, Mallion JM, Baguet JP (2008) EVAluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: the EVABAR study. J Hypertens 26:1373\u20131378. https:\/\/doi.org\/10.1097\/HJH.0b013e3283015e5a","journal-title":"J Hypertens"},{"key":"13086_CR27","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","volume":"17","author":"DC Velseboer","year":"2011","unstructured":"Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RM (2011) Prevalence of orthostatic hypotension in Parkinson\u2019s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 17:724\u2013729. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.04.016","journal-title":"Parkinsonism Relat Disord"},{"key":"13086_CR28","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1161\/01.str.31.10.2307","volume":"31","author":"ML Eigenbrodt","year":"2000","unstructured":"Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D (2000) Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987\u20131996. Stroke 31:2307\u20132313. https:\/\/doi.org\/10.1161\/01.str.31.10.2307","journal-title":"Stroke"},{"key":"13086_CR29","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1161\/01.cir.98.21.2290","volume":"98","author":"KH Masaki","year":"1998","unstructured":"Masaki KH, Schatz IJ, Burchfiel CM, Sharp DS, Chiu D, Foley D, Curb JD (1998) Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation 98:2290\u20132295. https:\/\/doi.org\/10.1161\/01.cir.98.21.2290","journal-title":"Circulation"},{"key":"13086_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/archinte.159.3.273","volume":"159","author":"H Luukinen","year":"1999","unstructured":"Luukinen H, Koski K, Laippala P, Kivel\u00e4 SL (1999) Prognosis of diastolic and systolic orthostatic hypotension in older persons. Arch Intern Med 159:273\u2013280. https:\/\/doi.org\/10.1001\/archinte.159.3.273","journal-title":"Arch Intern Med"},{"key":"13086_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s12265-020-10044-1","volume":"13","author":"A Soloveva","year":"2020","unstructured":"Soloveva A, Fedorova D, Villevalde S, Zvartau N, Mareev Y, Sitnikova M, Shlyakhto E, Fudim M (2020) Addressing orthostatic hypotension in heart failure: pathophysiology, clinical implications and perspectives. J Cardiovasc Transl Res 13:549\u2013569. https:\/\/doi.org\/10.1007\/s12265-020-10044-1","journal-title":"J Cardiovasc Transl Res"},{"key":"13086_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neucli.2021.12.007","volume":"52","author":"A Nasri","year":"2022","unstructured":"Nasri A, Kacem I, Farhat N, Gharbi A, Sakka S, Souissi A, Zidi S, Damak M, Bendjebara M, Gargouri A, Mhiri C, Gouider R (2022) Heart rate variability and sympathetic skin response for the assessment of autonomic dysfunction in leucine-rich repeat kinase 2 associated Parkinson\u2019s disease. Neurophysiol Clin 52:81\u201393. https:\/\/doi.org\/10.1016\/j.neucli.2021.12.007","journal-title":"Neurophysiol Clin"},{"key":"13086_CR33","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/mds.27989","volume":"35","author":"T Simuni","year":"2020","unstructured":"Simuni T, Brumm MC, Uribe L, Caspell-Garcia C, Coffey CS, Siderowf A, Alcalay RN, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Nudelman K, Tosun-Turgut D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Bressman S, Marek K (2020) Clinical and dopamine transporter imaging characteristics of Leucine Rich repeat kinase 2 (LRRK2) and glucosylceramidase beta (GBA) Parkinson\u2019s disease participants in the Parkinson\u2019s progression markers initiative: a cross-sectional study. Mov Disord 35:833\u2013844. https:\/\/doi.org\/10.1002\/mds.27989","journal-title":"Mov Disord"},{"key":"13086_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3233\/jpd-230334","volume":"14","author":"G Giannini","year":"2024","unstructured":"Giannini G, Minardi R, Barletta G, Cani I, Cecere A, Baldelli L, Fiorentino A, Guaraldi P, Sambati L, Capellari S, Cortelli P, Carelli V, Calandra-Buonaura G (2024) The degree of cardiovascular autonomic dysfunction is not different in GBA-related and idiopathic Parkinson\u2019s disease patients: a case-control instrumental evaluation. J Parkinsons Dis 14:335\u2013346. https:\/\/doi.org\/10.3233\/jpd-230334","journal-title":"J Parkinsons Dis"},{"key":"13086_CR35","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3233\/jpd-223197","volume":"12","author":"T Usnich","year":"2022","unstructured":"Usnich T, Hanssen H, Lohmann K, Lohse C, Klein C, Kasten M, Br\u00fcggemann N (2022) Pronounced orthostatic hypotension in GBA-related Parkinson\u2019s disease. J Parkinsons Dis 12:1539\u20131544. https:\/\/doi.org\/10.3233\/jpd-223197","journal-title":"J Parkinsons Dis"},{"key":"13086_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"K Marek","year":"2011","unstructured":"Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T, Coffey C, Kieburtz K, Flagg E, Chowdhury S, Poewe W (2011) The Parkinson progression marker initiative (PPMI). Prog Neurobiol 95:629\u2013635. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.09.005","journal-title":"Prog Neurobiol"},{"key":"13086_CR37","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/acn3.644","volume":"5","author":"K Marek","year":"2018","unstructured":"Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun-Turgut D, Poston K, Arnedo V, Frasier M, Sherer T (2018) The Parkinson\u2019s progression markers initiative (PPMI) - establishing a PD biomarker cohort. Ann Clin Transl Neurol 5:1460\u20131477. https:\/\/doi.org\/10.1002\/acn3.644","journal-title":"Ann Clin Transl Neurol"},{"key":"13086_CR38","doi-asserted-by":"publisher","first-page":"e685","DOI":"10.1212\/wnl.0000000000009989","volume":"95","author":"YE Huh","year":"2020","unstructured":"Huh YE, Chiang MSR, Locascio JJ, Liao Z, Liu G, Choudhury K, Kuras YI, Tuncali I, Videnovic A, Hunt AL, Schwarzschild MA, Hung AY, Herrington TM, Hayes MT, Hyman BT, Wills AM, Gomperts SN, Growdon JH, Sardi SP, Scherzer CR (2020) \u03b2-Glucocerebrosidase activity in GBA-linked Parkinson disease: the type of mutation matters. Neurology 95:e685\u2013e696. https:\/\/doi.org\/10.1212\/wnl.0000000000009989","journal-title":"Neurology"},{"key":"13086_CR39","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1212\/wnl.0000000000001315","volume":"84","author":"Z Gan-Or","year":"2015","unstructured":"Gan-Or Z, Amshalom I, Kilarski LL, Bar-Shira A, Gana-Weisz M, Mirelman A, Marder K, Bressman S, Giladi N, Orr-Urtreger A (2015) Differential effects of severe vs mild GBA mutations on Parkinson disease. Neurology 84:880\u2013887. https:\/\/doi.org\/10.1212\/wnl.0000000000001315","journal-title":"Neurology"},{"key":"13086_CR40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/ana.24781","volume":"80","author":"G Liu","year":"2016","unstructured":"Liu G, Boot B, Locascio JJ, Jansen IE, Winder-Rhodes S, Eberly S, Elbaz A, Brice A, Ravina B, van Hilten JJ, Cormier-Dequaire F, Corvol JC, Barker RA, Heutink P, Marinus J, Williams-Gray CH, Scherzer CR (2016) Specifically neuropathic Gaucher\u2019s mutations accelerate cognitive decline in Parkinson\u2019s. Ann Neurol 80:674\u2013685. https:\/\/doi.org\/10.1002\/ana.24781","journal-title":"Ann Neurol"},{"key":"13086_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/mds.26374","volume":"31","author":"MA Nalls","year":"2016","unstructured":"Nalls MA, Keller MF, Hernandez DG, Chen L, Stone DJ, Singleton AB (2016) Baseline genetic associations in the Parkinson\u2019s Progression Markers Initiative (PPMI). Mov Disord 31:79\u201385. https:\/\/doi.org\/10.1002\/mds.26374","journal-title":"Mov Disord"},{"key":"13086_CR42","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1212\/wnl.0000000000000960","volume":"83","author":"D Jennings","year":"2014","unstructured":"Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K (2014) Imaging prodromal Parkinson disease: the Parkinson associated risk syndrome study. Neurology 83:1739\u20131746. https:\/\/doi.org\/10.1212\/wnl.0000000000000960","journal-title":"Neurology"},{"key":"13086_CR43","doi-asserted-by":"publisher","first-page":"e108982","DOI":"10.1371\/journal.pone.0108982","volume":"9","author":"C Gaig","year":"2014","unstructured":"Gaig C, Vilas D, Infante J, Sierra M, Garc\u00eda-Gorostiaga I, Buongiorno M, Ezquerra M, Mart\u00ed MJ, Valldeoriola F, Aguilar M, Calopa M, Hernandez-Vara J, Tolosa E (2014) Nonmotor symptoms in LRRK2 G2019S associated Parkinson\u2019s disease. PLoS ONE 9:e108982. https:\/\/doi.org\/10.1371\/journal.pone.0108982","journal-title":"PLoS ONE"},{"key":"13086_CR44","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/s1474-4422(22)00169-7","volume":"21","author":"W Wieling","year":"2022","unstructured":"Wieling W, Kaufmann H, Claydon VE, van Wijnen VK, Harms MPM, Juraschek SP, Thijs RD (2022) Diagnosis and treatment of orthostatic hypotension. Lancet Neurol 21:735\u2013746. https:\/\/doi.org\/10.1016\/s1474-4422(22)00169-7","journal-title":"Lancet Neurol"},{"key":"13086_CR45","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/s0895-7061(99)00257-5","volume":"13","author":"KM Rose","year":"2000","unstructured":"Rose KM, Tyroler HA, Nardo CJ, Arnett DK, Light KC, Rosamond W, Sharrett AR, Szklo M (2000) Orthostatic hypotension and the incidence of coronary heart disease: the atherosclerosis risk in communities study. Am J Hypertens 13:571\u2013578. https:\/\/doi.org\/10.1016\/s0895-7061(99)00257-5","journal-title":"Am J Hypertens"},{"key":"13086_CR46","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaneurol.2018.1487","volume":"75","author":"J Jankovic","year":"2018","unstructured":"Jankovic J, Goodman I, Safirstein B, Marmon TK, Schenk DB, Koller M, Zago W, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaacson SH, Omidvar O, Ellenbogen A, Kinney GG (2018) Safety and tolerability of multiple ascending doses of PRX002\/RG7935, an anti\u2013\u03b1-synuclein monoclonal antibody, in patients with parkinson disease: a randomized clinical trial. JAMA Neurol 75:1206\u20131214. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1487","journal-title":"JAMA Neurol"},{"key":"13086_CR47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s40478-021-01283-7","volume":"9","author":"CF Brzozowski","year":"2021","unstructured":"Brzozowski CF, Hijaz BA, Singh V, Gcwensa NZ, Kelly K, Boyden ES, West AB, Sarkar D, Volpicelli-Daley LA (2021) Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of \u03b1-synuclein. Acta Neuropathol Commun 9:180. https:\/\/doi.org\/10.1186\/s40478-021-01283-7","journal-title":"Acta Neuropathol Commun"},{"key":"13086_CR48","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/mds.23773","volume":"26","author":"J Ruiz-Mart\u00ednez","year":"2011","unstructured":"Ruiz-Mart\u00ednez J, Gorostidi A, Goyenechea E, Alzualde A, Poza JJ, Rodr\u00edguez F, Bergareche A, Moreno F, L\u00f3pez de Munain A, Mart\u00ed Mass\u00f3 JF (2011) Olfactory deficits and cardiac 123I-MIBG in Parkinson\u2019s disease related to the LRRK2 R1441G and G2019S mutations. Mov Disord 26:2026\u20132031. https:\/\/doi.org\/10.1002\/mds.23773","journal-title":"Mov Disord"},{"key":"13086_CR49","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.parkreldis.2013.05.008","volume":"19","author":"B Tijero","year":"2013","unstructured":"Tijero B, G\u00f3mez Esteban JC, Somme J, Llorens V, Lezcano E, Martinez A, Rodr\u00edguez T, Berganzo K, Zarranz JJ (2013) Autonomic dysfunction in parkinsonian LRRK2 mutation carriers. Parkinsonism Relat Disord 19:906\u2013909. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.05.008","journal-title":"Parkinsonism Relat Disord"},{"key":"13086_CR50","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-34261\/v1","author":"D Vilas","year":"2020","unstructured":"Vilas D, Tolosa E, Aldecoa I et al (2020) Alpha-synuclein pathology in the submandibular gland of LRRK2 p. G2019S mutation carriers. Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-34261\/v1","journal-title":"Res Square"},{"key":"13086_CR51","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cell.2014.01.064","volume":"157","author":"I Martin","year":"2014","unstructured":"Martin I, Kim JW, Lee BD, Kang HC, Xu JC, Jia H, Stankowski J, Kim MS, Zhong J, Kumar M, Andrabi SA, Xiong Y, Dickson DW, Wszolek ZK, Pandey A, Dawson TM, Dawson VL (2014) Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson\u2019s disease. Cell 157:472\u2013485. https:\/\/doi.org\/10.1016\/j.cell.2014.01.064","journal-title":"Cell"},{"key":"13086_CR52","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1136\/jnnp-2017-317348","volume":"89","author":"N Malek","year":"2018","unstructured":"Malek N, Weil RS, Bresner C, Lawton MA, Grosset KA, Tan M, Bajaj N, Barker RA, Burn DJ, Foltynie T, Hardy J, Wood NW, Ben-Shlomo Y, Williams NW, Grosset DG, Morris HR (2018) Features of GBA-associated Parkinson\u2019s disease at presentation in the UK Tracking Parkinson\u2019s study. J Neurol Neurosurg Psychiatry 89:702\u2013709. https:\/\/doi.org\/10.1136\/jnnp-2017-317348","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13086_CR53","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1093\/brain\/awu291","volume":"137","author":"I Fishbein","year":"2014","unstructured":"Fishbein I, Kuo YM, Giasson BI, Nussbaum RL (2014) Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation. Brain 137:3235\u20133247. https:\/\/doi.org\/10.1093\/brain\/awu291","journal-title":"Brain"},{"key":"13086_CR54","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ana.23614","volume":"72","author":"ME Gegg","year":"2012","unstructured":"Gegg ME, Burke D, Heales SJ, Cooper JM, Hardy J, Wood NW, Schapira AH (2012) Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann Neurol 72:455\u2013463. https:\/\/doi.org\/10.1002\/ana.23614","journal-title":"Ann Neurol"},{"key":"13086_CR55","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1016\/j.neurobiolaging.2015.08.027","volume":"36","author":"T Oeda","year":"2015","unstructured":"Oeda T, Umemura A, Mori Y, Tomita S, Kohsaka M, Park K, Inoue K, Fujimura H, Hasegawa H, Sugiyama H, Sawada H (2015) Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson\u2019s disease. Neurobiol Aging 36:3306\u20133313. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.08.027","journal-title":"Neurobiol Aging"},{"key":"13086_CR56","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/ene.15615","volume":"30","author":"MS Kim","year":"2023","unstructured":"Kim MS, Park DG, An YS, Yoon JH (2023) Dual-phase (18) F-FP-CIT positron emission tomography and cardiac (123) I-MIBG scintigraphy of Parkinson\u2019s disease patients with GBA mutations: evidence of the body-first type? Eur J Neurol 30:344\u2013352. https:\/\/doi.org\/10.1111\/ene.15615","journal-title":"Eur J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13086-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13086-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13086-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T12:41:56Z","timestamp":1747658516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13086-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["13086"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13086-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or nonfinancial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The data were retrieved from the PPMI, an online database that provides de-identified clinical data. That study was conducted in accordance with the Declaration of Helsinki and the Good Clinical Practice (GCP) guidelines after approval of the local ethics committees of the participating sites. For up-to-date information on the study, visit .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The PPMI study protocol was registered on June 8, 2010 (ClinicalTrials.gov identifer: NCT01141023). The study was approved by the institutinal review board at each research site. All participants provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"369"}}